Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model

ASN Neuro. 2014 Nov 24;6(6):1759091414554945. doi: 10.1177/1759091414554945. Print 2014.

Abstract

Creatine is the substrate for creatine kinase in the synthesis of phosphocreatine (PCr). This energetic system is endowed of antioxidant and neuroprotective properties and plays a pivotal role in brain energy homeostasis. The purpose of this study was to investigate the neuroprotective effect of creatine and PCr against 6-hydroxydopamine (6-OHDA)-induced mitochondrial dysfunction and cell death in rat striatal slices, used as an in vitro Parkinson's model. The possible involvement of the signaling pathway mediated by phosphatidylinositol-3 kinase (PI3K), protein kinase B (Akt), and glycogen synthase kinase-3β (GSK3β) was also evaluated. Exposure of striatal slices to 6-OHDA caused a significant disruption of the cellular homeostasis measured as 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide reduction, lactate dehydrogenase release, and tyrosine hydroxylase levels. 6-OHDA exposure increased the levels of reactive oxygen species and thiobarbituric acid reactive substances production and decreased mitochondrial membrane potential in rat striatal slices. Furthermore, 6-OHDA decreased the phosphorylation of Akt (Serine(473)) and GSK3β (Serine(9)). Coincubation with 6-OHDA and creatine or PCr reduced the effects of 6-OHDA toxicity. The protective effect afforded by creatine or PCr against 6-OHDA-induced toxicity was reversed by the PI3K inhibitor LY294002. In conclusion, creatine and PCr minimize oxidative stress in striatum to afford neuroprotection of dopaminergic neurons.

Keywords: 6-OHDA; PI3K; creatine; neuroprotective; oxidative stress; phosphocreatine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / pharmacology
  • Animals
  • Cell Death / drug effects
  • Chromones / pharmacology
  • Corpus Striatum / drug effects*
  • Creatine / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Glycogen Synthase Kinase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta
  • In Vitro Techniques
  • L-Lactate Dehydrogenase / metabolism
  • Lipid Peroxidation / drug effects
  • Male
  • Membrane Potential, Mitochondrial / drug effects
  • Mice, Inbred C57BL
  • Morpholines / pharmacology
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects*
  • Oxidopamine / pharmacology
  • Phosphatidylinositol 3-Kinase
  • Phosphocreatine / pharmacology*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Adrenergic Agents
  • Chromones
  • Enzyme Inhibitors
  • Morpholines
  • Neuroprotective Agents
  • Phosphocreatine
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Oxidopamine
  • L-Lactate Dehydrogenase
  • Phosphatidylinositol 3-Kinase
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Gsk3b protein, rat
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3
  • Creatine